Market Tracker

01/20 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

10.22
Delayed Data
As of Jan 20
 +0.07 / +0.69%
Today’s Change
8.10
Today|||52-Week Range
16.54
-2.29%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close10.15
Today’s open10.25
Day’s range10.18 - 10.29
Volume18,057
Average volume (3 months)54,948
Market cap$174.3M
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-60.54%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.96%
P/E ratio--
Price/Sales47,981.20
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
OCXOncoCyte Corp-0.05-0.83%
GNMXAevi Genomic Medicin...-0.02-0.41%
MDGLMadrigal Pharmaceuti...+0.08+0.51%
NBRVNabriva Therapeutics...+0.07+0.90%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$3.0K
Annual profit (last year)-$21.1M
Net profit margin-703,000.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts